INTEGRATIVE MOLECULAR CHARACTERIZATION AND BIOMARKER VALIDATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)
$854,195FY2021Department of the ArmyDOD
University Of Melbourne, Melbourne
Investigators
View source on USAspending →INTEGRATIVE MOLECULAR CHARACTERIZATION AND BIOMARKER VALIDATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) · GrantIndex